Clinical Trial Update: Galunisertib Combined With Capecitabine in Advanced CRC With PM [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating galunisertib in combination with capecitabine for advanced colorectal cancer with peritoneal carcinomatosis. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• Capecitabine (capecitabine)
• Galunisertib (galunisertib)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Colorectal Cancer Metastatic, Peritoneal Carcinomatosis | Phase 1, Phase 2 | Status: RECRUITING